HEADER IMMUNE SYSTEM 13-FEB-20 6VTU TITLE DH717.1 FAB MONOMER IN COMPLEX WITH MAN9 GLYCAN COMPND MOL_ID: 1; COMPND 2 MOLECULE: DH717.1 HEAVY CHAIN; COMPND 3 CHAIN: H; COMPND 4 FRAGMENT: FAB,FAB; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: DH717.1 LIGHT CHAIN; COMPND 8 CHAIN: L; COMPND 9 FRAGMENT: FAB,FAB; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 CELL_LINE: HEK293T; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: HEK293T; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PVRC-8400; SOURCE 12 MOL_ID: 2; SOURCE 13 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 14 ORGANISM_COMMON: HUMAN; SOURCE 15 ORGANISM_TAXID: 9606; SOURCE 16 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 17 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 18 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS FAB FRAGMENT, HIV-1, ANTIBODY, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR D.FERA,N.BRONKEMA REVDAT 5 23-OCT-24 6VTU 1 REMARK REVDAT 4 11-OCT-23 6VTU 1 REMARK REVDAT 3 09-JUN-21 6VTU 1 JRNL REVDAT 2 02-JUN-21 6VTU 1 JRNL REVDAT 1 30-DEC-20 6VTU 0 JRNL AUTH W.B.WILLIAMS,R.R.MEYERHOFF,R.J.EDWARDS,H.LI,K.MANNE, JRNL AUTH 2 N.I.NICELY,R.HENDERSON,Y.ZHOU,K.JANOWSKA,K.MANSOURI, JRNL AUTH 3 S.GOBEIL,T.EVANGELOUS,B.HORA,M.BERRY,A.Y.ABUAHMAD,J.SPRENZ, JRNL AUTH 4 M.DEYTON,V.STALLS,M.KOPP,A.L.HSU,M.J.BORGNIA, JRNL AUTH 5 G.B.E.STEWART-JONES,M.S.LEE,N.BRONKEMA,M.A.MOODY,K.WIEHE, JRNL AUTH 6 T.BRADLEY,S.M.ALAM,R.J.PARKS,A.FOULGER,T.OGUIN, JRNL AUTH 7 G.D.SEMPOWSKI,M.BONSIGNORI,C.C.LABRANCHE,D.C.MONTEFIORI, JRNL AUTH 8 M.SEAMAN,S.SANTRA,J.PERFECT,J.R.FRANCICA,G.M.LYNN, JRNL AUTH 9 B.AUSSEDAT,W.E.WALKOWICZ,R.LAGA,G.KELSOE,K.O.SAUNDERS, JRNL AUTH10 D.FERA,P.D.KWONG,R.A.SEDER,A.BARTESAGHI,G.M.SHAW,P.ACHARYA, JRNL AUTH11 B.F.HAYNES JRNL TITL FAB-DIMERIZED GLYCAN-REACTIVE ANTIBODIES ARE A STRUCTURAL JRNL TITL 2 CATEGORY OF NATURAL ANTIBODIES. JRNL REF CELL V. 184 2955 2021 JRNL REFN ISSN 1097-4172 JRNL PMID 34019795 JRNL DOI 10.1016/J.CELL.2021.04.042 REMARK 2 REMARK 2 RESOLUTION. 2.61 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.8.2 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.61 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 49.73 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 3 NUMBER OF REFLECTIONS : 20338 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.193 REMARK 3 R VALUE (WORKING SET) : 0.191 REMARK 3 FREE R VALUE : 0.224 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.880 REMARK 3 FREE R VALUE TEST SET COUNT : 993 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 49.7320 - 4.9913 0.96 2887 130 0.1828 0.2106 REMARK 3 2 4.9913 - 3.9623 0.98 2814 131 0.1490 0.1718 REMARK 3 3 3.9623 - 3.4616 0.99 2781 141 0.1777 0.2126 REMARK 3 4 3.4616 - 3.1451 0.99 2761 154 0.2008 0.2468 REMARK 3 5 3.1451 - 2.9197 1.00 2759 151 0.2403 0.2799 REMARK 3 6 2.9197 - 2.7476 0.99 2731 141 0.2508 0.2805 REMARK 3 7 2.7476 - 2.6100 0.95 2612 145 0.2820 0.3024 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.220 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.510 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 49.17 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 46.94 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 3288 REMARK 3 ANGLE : 0.811 4489 REMARK 3 CHIRALITY : 0.053 524 REMARK 3 PLANARITY : 0.004 572 REMARK 3 DIHEDRAL : 13.307 1155 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): -15.9227 52.8128 -23.2067 REMARK 3 T TENSOR REMARK 3 T11: 0.1835 T22: 0.1563 REMARK 3 T33: 0.1674 T12: -0.0064 REMARK 3 T13: 0.0013 T23: -0.0166 REMARK 3 L TENSOR REMARK 3 L11: 0.2644 L22: 0.4994 REMARK 3 L33: 0.5477 L12: -0.0848 REMARK 3 L13: 0.2814 L23: -0.5136 REMARK 3 S TENSOR REMARK 3 S11: -0.0722 S12: -0.0160 S13: -0.0080 REMARK 3 S21: 0.1355 S22: 0.0383 S23: -0.0553 REMARK 3 S31: -0.0855 S32: -0.0708 S33: -0.0004 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6VTU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-FEB-20. REMARK 100 THE DEPOSITION ID IS D_1000247071. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-FEB-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 24-ID-E REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97927 REMARK 200 MONOCHROMATOR : SINGLE CRYSTAL SI(220) SIDE REMARK 200 BOUNCE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20471 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.610 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 200 DATA REDUNDANCY : 4.400 REMARK 200 R MERGE (I) : 0.14900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.61 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.66 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.3 REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : 0.88400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.8.2 REMARK 200 STARTING MODEL: PDB ENTRY 5TPP REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 65.29 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.54 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM SODIUM CITRATE, PH 5.0, 30% REMARK 280 PEG4000, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 49.23800 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 57.61900 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 57.61900 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 24.61900 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 57.61900 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 57.61900 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 73.85700 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 57.61900 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 57.61900 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 24.61900 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 57.61900 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 57.61900 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 73.85700 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 49.23800 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4290 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19830 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -12.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: H, L, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER H 127A REMARK 465 LYS H 127B REMARK 465 SER H 127C REMARK 465 THR H 127D REMARK 465 SER H 127E REMARK 465 GLU L 210 REMARK 465 CYS L 211 REMARK 465 SER L 212 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU H 97 CG CD OE1 OE2 REMARK 470 ASN H 199 CG OD1 ND2 REMARK 470 GLU L 81 CD OE1 OE2 REMARK 470 GLU L 94 CG CD OE1 OE2 REMARK 470 GLN L 108 CG CD OE1 NE2 REMARK 470 LYS L 110 CG CD CE NZ REMARK 470 GLN L 126 CG CD OE1 NE2 REMARK 470 LYS L 149 CG CD CE NZ REMARK 470 ASP L 151 CG OD1 OD2 REMARK 470 LYS L 156 CG CD CE NZ REMARK 470 LYS L 166 CG CD CE NZ REMARK 470 LYS L 186 CG CD CE NZ REMARK 470 ARG L 189 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 SG CYS H 135 CB CYS H 191 2.02 REMARK 500 O GLY H 52A NZ LYS H 71 2.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL H 2 95.76 56.04 REMARK 500 SER H 15 -20.11 72.62 REMARK 500 LYS H 43 -167.12 -116.61 REMARK 500 SER H 100E 73.06 -115.90 REMARK 500 ASP H 139 73.58 54.68 REMARK 500 ASP L 27B -82.11 -120.08 REMARK 500 ASN L 31 44.42 -104.92 REMARK 500 VAL L 51 -49.40 69.51 REMARK 500 GLU L 94 32.58 88.18 REMARK 500 ASP L 151 -91.92 55.16 REMARK 500 SER L 187 54.15 -90.37 REMARK 500 GLU L 198 90.94 -47.23 REMARK 500 PRO L 208 85.41 -69.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 MAN A 1 DBREF 6VTU H 1 113 PDB 6VTU 6VTU 1 113 DBREF 6VTU H 114 209 UNP S6B291 S6B291_HUMAN 137 237 DBREF 6VTU L 1 111 PDB 6VTU 6VTU 1 111 DBREF 6VTU L 112 212 UNP Q6IPQ0 Q6IPQ0_HUMAN 136 236 SEQRES 1 H 225 GLN VAL GLN LEU GLN GLU SER GLY PRO GLY LEU VAL LYS SEQRES 2 H 225 PRO SER GLU THR LEU SER LEU THR CYS ALA VAL SER GLY SEQRES 3 H 225 VAL SER ILE ASN ASP GLY TYR ASP TRP THR TRP ILE ARG SEQRES 4 H 225 GLN THR PRO GLY LYS GLY LEU GLU TRP ILE GLY TYR VAL SEQRES 5 H 225 PHE GLY ARG SER GLY ASN PHE ASN LEU ASN PRO SER LEU SEQRES 6 H 225 ARG ASN ARG GLY ILE ILE SER LYS ASP THR CYS LYS ASN SEQRES 7 H 225 GLN PHE SER LEU ASN LEU ASN SER ALA THR ALA ALA ASP SEQRES 8 H 225 THR ALA VAL TYR PHE CYS ALA ARG GLY MET GLU GLY LEU SEQRES 9 H 225 PHE ALA ALA TYR ASN SER LEU ASP VAL TRP GLY ARG GLY SEQRES 10 H 225 LEU LEU VAL THR VAL SER GLY ALA SER THR LYS GLY PRO SEQRES 11 H 225 SER VAL PHE PRO LEU ALA PRO SER SER LYS SER THR SER SEQRES 12 H 225 GLY GLY THR ALA ALA LEU GLY CYS LEU VAL LYS ASP TYR SEQRES 13 H 225 PHE PRO GLU PRO VAL THR VAL SER TRP ASN SER GLY ALA SEQRES 14 H 225 LEU THR SER GLY VAL HIS THR PHE PRO ALA VAL LEU GLN SEQRES 15 H 225 SER SER GLY LEU TYR SER LEU SER SER VAL VAL THR VAL SEQRES 16 H 225 PRO SER SER SER LEU GLY THR GLN THR TYR ILE CYS ASN SEQRES 17 H 225 VAL ASN HIS LYS PRO SER ASN THR LYS VAL ASP LYS ARG SEQRES 18 H 225 VAL GLU PRO LYS SEQRES 1 L 216 GLN ALA ALA LEU THR GLN PRO PRO SER VAL SER GLY SER SEQRES 2 L 216 PRO GLY GLN SER VAL ILE ILE SER CYS THR GLY THR SER SEQRES 3 L 216 SER ASP ILE GLY GLN TYR ASN SER VAL SER TRP TYR GLN SEQRES 4 L 216 GLN HIS PRO ASP LYS ALA PRO LYS LEU VAL ILE TYR GLY SEQRES 5 L 216 VAL THR SER ARG PRO SER GLY VAL SER ASP ARG PHE SER SEQRES 6 L 216 GLY SER LYS TYR GLY ASP THR ALA SER LEU THR ILE SER SEQRES 7 L 216 GLY LEU GLN ALA GLU ASP GLU ALA ASP TYR TYR CYS SER SEQRES 8 L 216 SER HIS ALA ASP GLU ASN MET ALA LEU PHE GLY GLY GLY SEQRES 9 L 216 THR ARG LEU THR VAL LEU GLY GLN PRO LYS GLY ALA PRO SEQRES 10 L 216 SER VAL THR LEU PHE PRO PRO SER SER GLU GLU LEU GLN SEQRES 11 L 216 ALA ASN LYS ALA THR LEU VAL CYS LEU ILE SER ASP PHE SEQRES 12 L 216 TYR PRO GLY ALA VAL THR VAL ALA TRP LYS ALA ASP SER SEQRES 13 L 216 SER PRO VAL LYS ALA GLY VAL GLU THR THR THR PRO SER SEQRES 14 L 216 LYS GLN SER ASN ASN LYS TYR ALA ALA SER SER TYR LEU SEQRES 15 L 216 SER LEU THR PRO GLU GLN TRP LYS SER HIS ARG SER TYR SEQRES 16 L 216 SER CYS GLN VAL THR HIS GLU GLY SER THR VAL GLU LYS SEQRES 17 L 216 THR VAL ALA PRO THR GLU CYS SER HET MAN A 1 11 HET MAN A 2 11 HET MAN A 3 11 HET GOL H 301 6 HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM GOL GLYCEROL HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 MAN 3(C6 H12 O6) FORMUL 4 GOL C3 H8 O3 FORMUL 5 HOH *155(H2 O) HELIX 1 AA1 THR H 83 THR H 87 5 5 HELIX 2 AA2 ALA H 100A ASN H 100D 5 4 HELIX 3 AA3 SER H 151 ALA H 153 5 3 HELIX 4 AA4 SER H 182 LEU H 184 5 3 HELIX 5 AA5 LYS H 196 ASN H 199 5 4 HELIX 6 AA6 GLN L 79 GLU L 83 5 5 HELIX 7 AA7 SER L 121 GLN L 126 1 6 HELIX 8 AA8 THR L 181 SER L 187 1 7 SHEET 1 AA1 4 GLN H 3 SER H 7 0 SHEET 2 AA1 4 LEU H 18 SER H 25 -1 O ALA H 23 N GLN H 5 SHEET 3 AA1 4 GLN H 77 LEU H 82 -1 O LEU H 82 N LEU H 18 SHEET 4 AA1 4 GLY H 67 ASP H 72 -1 N ASP H 72 O GLN H 77 SHEET 1 AA2 6 LEU H 11 VAL H 12 0 SHEET 2 AA2 6 LEU H 107 VAL H 111 1 O THR H 110 N VAL H 12 SHEET 3 AA2 6 ALA H 88 GLY H 95 -1 N TYR H 90 O LEU H 107 SHEET 4 AA2 6 ASP H 34 GLN H 39 -1 N ILE H 37 O PHE H 91 SHEET 5 AA2 6 GLU H 46 PHE H 52 -1 O VAL H 51 N TRP H 35 SHEET 6 AA2 6 PHE H 57 LEU H 59 -1 O ASN H 58 N TYR H 50 SHEET 1 AA3 4 LEU H 11 VAL H 12 0 SHEET 2 AA3 4 LEU H 107 VAL H 111 1 O THR H 110 N VAL H 12 SHEET 3 AA3 4 ALA H 88 GLY H 95 -1 N TYR H 90 O LEU H 107 SHEET 4 AA3 4 LEU H 100F TRP H 103 -1 O VAL H 102 N ARG H 94 SHEET 1 AA4 4 SER H 120 LEU H 124 0 SHEET 2 AA4 4 THR H 130 TYR H 140 -1 O GLY H 134 N LEU H 124 SHEET 3 AA4 4 TYR H 171 PRO H 180 -1 O VAL H 179 N ALA H 131 SHEET 4 AA4 4 VAL H 158 THR H 160 -1 N HIS H 159 O VAL H 176 SHEET 1 AA5 4 SER H 120 LEU H 124 0 SHEET 2 AA5 4 THR H 130 TYR H 140 -1 O GLY H 134 N LEU H 124 SHEET 3 AA5 4 TYR H 171 PRO H 180 -1 O VAL H 179 N ALA H 131 SHEET 4 AA5 4 VAL H 164 LEU H 165 -1 N VAL H 164 O SER H 172 SHEET 1 AA6 3 THR H 146 TRP H 149 0 SHEET 2 AA6 3 ILE H 190 HIS H 195 -1 O ASN H 192 N SER H 148 SHEET 3 AA6 3 THR H 200 ARG H 205 -1 O LYS H 204 N CYS H 191 SHEET 1 AA7 5 SER L 9 GLY L 13 0 SHEET 2 AA7 5 THR L 102 VAL L 106 1 O THR L 105 N VAL L 11 SHEET 3 AA7 5 ASP L 85 ALA L 92 -1 N TYR L 86 O THR L 102 SHEET 4 AA7 5 VAL L 33 GLN L 38 -1 N TYR L 36 O TYR L 87 SHEET 5 AA7 5 LYS L 45 ILE L 48 -1 O ILE L 48 N TRP L 35 SHEET 1 AA8 4 SER L 9 GLY L 13 0 SHEET 2 AA8 4 THR L 102 VAL L 106 1 O THR L 105 N VAL L 11 SHEET 3 AA8 4 ASP L 85 ALA L 92 -1 N TYR L 86 O THR L 102 SHEET 4 AA8 4 MET L 95A PHE L 98 -1 O LEU L 97 N SER L 90 SHEET 1 AA9 3 VAL L 19 THR L 24 0 SHEET 2 AA9 3 THR L 70 ILE L 75 -1 O ALA L 71 N CYS L 23 SHEET 3 AA9 3 PHE L 62 TYR L 67 -1 N SER L 63 O THR L 74 SHEET 1 AB1 4 SER L 114 PHE L 118 0 SHEET 2 AB1 4 ALA L 130 PHE L 139 -1 O LEU L 135 N THR L 116 SHEET 3 AB1 4 TYR L 172 LEU L 180 -1 O ALA L 174 N ILE L 136 SHEET 4 AB1 4 VAL L 159 THR L 161 -1 N GLU L 160 O TYR L 177 SHEET 1 AB2 4 SER L 114 PHE L 118 0 SHEET 2 AB2 4 ALA L 130 PHE L 139 -1 O LEU L 135 N THR L 116 SHEET 3 AB2 4 TYR L 172 LEU L 180 -1 O ALA L 174 N ILE L 136 SHEET 4 AB2 4 SER L 165 LYS L 166 -1 N SER L 165 O ALA L 173 SHEET 1 AB3 4 SER L 153 VAL L 155 0 SHEET 2 AB3 4 THR L 145 ALA L 150 -1 N ALA L 150 O SER L 153 SHEET 3 AB3 4 TYR L 191 THR L 196 -1 O THR L 196 N THR L 145 SHEET 4 AB3 4 THR L 201 VAL L 206 -1 O VAL L 202 N VAL L 195 SSBOND 1 CYS H 22 CYS H 92 1555 1555 2.04 SSBOND 2 CYS H 135 CYS H 191 1555 1555 2.03 SSBOND 3 CYS L 23 CYS L 88 1555 1555 2.03 SSBOND 4 CYS L 134 CYS L 193 1555 1555 2.03 LINK O2 MAN A 1 C1 MAN A 2 1555 1555 1.43 LINK O2 MAN A 2 C1 MAN A 3 1555 1555 1.43 CISPEP 1 PHE H 141 PRO H 142 0 -3.77 CISPEP 2 GLU H 143 PRO H 144 0 -1.62 CISPEP 3 TYR L 140 PRO L 141 0 0.92 CRYST1 115.238 115.238 98.476 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008678 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008678 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010155 0.00000